Antineoplastics: what the agencies decided
145 molecules in ATC class L01 with a published cross-agency decision record.
| Molecule | Decisions | Agencies | Class |
|---|---|---|---|
| pembrolizumab | 371 | 15 | Antineoplastics |
| nivolumab | 264 | 15 | Antineoplastics |
| atezolizumab | 120 | 14 | Antineoplastics |
| daratumumab | 115 | 15 | Antineoplastics |
| olaparib | 114 | 15 | Antineoplastics |
| durvalumab | 108 | 15 | Antineoplastics |
| ibrutinib | 108 | 15 | Antineoplastics |
| rituximab | 94 | 9 | Antineoplastics |
| bevacizumab | 77 | 10 | Antineoplastics |
| aflibercept | 67 | 11 | Antineoplastics |
| osimertinib | 65 | 14 | Antineoplastics |
| blinatumomab | 64 | 14 | Antineoplastics |
| trastuzumab deruxtecan | 64 | 14 | Antineoplastics |
| everolimus | 61 | 9 | Antineoplastics |
| venetoclax | 61 | 14 | Antineoplastics |
| ipilimumab | 58 | 14 | Antineoplastics |
| zanubrutinib | 58 | 16 | Antineoplastics |
| trastuzumab | 57 | 9 | Antineoplastics |
| cabozantinib | 56 | 15 | Antineoplastics |
| cemiplimab | 55 | 13 | Antineoplastics |
| brentuximab vedotin | 54 | 12 | Antineoplastics |
| selpercatinib | 53 | 13 | Antineoplastics |
| acalabrutinib | 52 | 14 | Antineoplastics |
| ribociclib | 50 | 14 | Antineoplastics |
| ruxolitinib | 50 | 12 | Antineoplastics |
| lenvatinib | 49 | 14 | Antineoplastics |
| nintedanib | 49 | 15 | Antineoplastics |
| tislelizumab | 48 | 12 | Antineoplastics |
| abemaciclib | 47 | 15 | Antineoplastics |
| amivantamab | 47 | 13 | Antineoplastics |
| avelumab | 42 | 13 | Antineoplastics |
| niraparib | 42 | 15 | Antineoplastics |
| dostarlimab | 39 | 14 | Antineoplastics |
| dabrafenib | 38 | 14 | Antineoplastics |
| isatuximab | 38 | 12 | Antineoplastics |
| alectinib | 37 | 15 | Antineoplastics |
| obinutuzumab | 37 | 12 | Antineoplastics |
| tisagenlecleucel | 37 | 12 | Antineoplastics |
| crizotinib | 35 | 12 | Antineoplastics |
| axicabtagene ciloleucel | 34 | 12 | Antineoplastics |
| cetuximab | 34 | 9 | Antineoplastics |
| carfilzomib | 32 | 11 | Antineoplastics |
| pertuzumab | 32 | 13 | Antineoplastics |
| bortezomib | 31 | 7 | Antineoplastics |
| ramucirumab | 31 | 9 | Antineoplastics |
| sacituzumab govitecan | 31 | 15 | Antineoplastics |
| avapritinib | 30 | 11 | Antineoplastics |
| entrectinib | 30 | 13 | Antineoplastics |
| idelalisib | 30 | 8 | Antineoplastics |
| imatinib | 30 | 6 | Antineoplastics |
| regorafenib | 30 | 12 | Antineoplastics |
| larotrectinib | 29 | 14 | Antineoplastics |
| palbociclib | 29 | 13 | Antineoplastics |
| encorafenib | 28 | 12 | Antineoplastics |
| dasatinib | 27 | 8 | Antineoplastics |
| enfortumab vedotin | 27 | 13 | Antineoplastics |
| lisocabtagene maraleucel | 27 | 11 | Antineoplastics |
| pemetrexed | 27 | 6 | Antineoplastics |
| glofitamab | 26 | 13 | Antineoplastics |
| lorlatinib | 26 | 12 | Antineoplastics |
| azacitidine | 25 | 11 | Antineoplastics |
| brigatinib | 25 | 14 | Antineoplastics |
| docetaxel | 25 | 7 | Antineoplastics |
| talazoparib | 25 | 13 | Antineoplastics |
| paclitaxel | 24 | 6 | Antineoplastics |
| bendamustine | 23 | 6 | Antineoplastics |
| epcoritamab | 23 | 14 | Antineoplastics |
| polatuzumab vedotin | 23 | 13 | Antineoplastics |
| asciminib | 22 | 15 | Antineoplastics |
| midostaurin | 22 | 11 | Antineoplastics |
| selinexor | 22 | 11 | Antineoplastics |
| belantamab mafodotin | 21 | 10 | Antineoplastics |
| ivosidenib | 21 | 12 | Antineoplastics |
| pirtobrutinib | 20 | 14 | Antineoplastics |
| trastuzumab emtansine | 20 | 12 | Antineoplastics |
| brexucabtagene autoleucel | 19 | 8 | Antineoplastics |
| tucatinib | 19 | 13 | Antineoplastics |
| belzutifan | 18 | 13 | Antineoplastics |
| eribulin | 18 | 9 | Antineoplastics |
| gilteritinib | 18 | 13 | Antineoplastics |
| irinotecan | 18 | 4 | Antineoplastics |
| selumetinib | 18 | 14 | Antineoplastics |
| sorafenib | 18 | 8 | Antineoplastics |
| sotorasib | 18 | 12 | Antineoplastics |
| trametinib | 18 | 8 | Antineoplastics |
| ceritinib | 17 | 9 | Antineoplastics |
| ciltacabtagene autoleucel | 17 | 10 | Antineoplastics |
| erlotinib | 17 | 6 | Antineoplastics |
| gemcitabine | 17 | 5 | Antineoplastics |
| rucaparib | 17 | 9 | Antineoplastics |
| sunitinib | 17 | 9 | Antineoplastics |
| teclistamab | 17 | 12 | Antineoplastics |
| topotecan | 17 | 7 | Antineoplastics |
| bosutinib | 16 | 10 | Antineoplastics |
| idecabtagene vicleucel | 16 | 9 | Antineoplastics |
| ripretinib | 16 | 12 | Antineoplastics |
| tafasitamab | 16 | 12 | Antineoplastics |
| fedratinib | 15 | 12 | Antineoplastics |
| ipilimumab / nivolumab | 15 | 6 | Antineoplastics |
| mogamulizumab | 15 | 11 | Antineoplastics |
| zolbetuximab | 15 | 12 | Antineoplastics |
| cabazitaxel | 14 | 7 | Antineoplastics |
| fruquintinib | 14 | 13 | Antineoplastics |
| ixazomib | 14 | 10 | Antineoplastics |
| pazopanib | 14 | 7 | Antineoplastics |
| pemigatinib | 14 | 12 | Antineoplastics |
| ponatinib | 14 | 9 | Antineoplastics |
| tebentafusp | 14 | 12 | Antineoplastics |
| trabectedin | 14 | 6 | Antineoplastics |
| capecitabine | 13 | 5 | Antineoplastics |
| elotuzumab | 13 | 8 | Antineoplastics |
| pertuzumab / trastuzumab | 13 | 7 | Antineoplastics |
| pralsetinib | 13 | 12 | Antineoplastics |
| inotuzumab ozogamicin | 12 | 10 | Antineoplastics |
| vismodegib | 12 | 8 | Antineoplastics |
| capivasertib | 11 | 9 | Antineoplastics |
| dinutuximab beta | 11 | 8 | Antineoplastics |
| futibatinib | 11 | 9 | Antineoplastics |
| gefitinib | 11 | 7 | Antineoplastics |
| gemtuzumab ozogamicin | 11 | 10 | Antineoplastics |
| neratinib | 11 | 10 | Antineoplastics |
| nilotinib | 11 | 5 | Antineoplastics |
| panitumumab | 11 | 6 | Antineoplastics |
| tepotinib | 11 | 10 | Antineoplastics |
| toripalimab | 11 | 8 | Antineoplastics |
| vandetanib | 11 | 7 | Antineoplastics |
| afatinib | 10 | 6 | Antineoplastics |
| alpelisib | 10 | 10 | Antineoplastics |
| hydroxycarbamide | 10 | 4 | Antineoplastics |
| lapatinib | 10 | 5 | Antineoplastics |
| mosunetuzumab | 10 | 7 | Antineoplastics |
| tarlatamab | 10 | 7 | Antineoplastics |
| axitinib | 9 | 8 | Antineoplastics |
| sonidegib | 9 | 7 | Antineoplastics |
| tremelimumab | 9 | 5 | Antineoplastics |
| treosulfan | 9 | 6 | Antineoplastics |
| vemurafenib | 9 | 8 | Antineoplastics |
| loncastuximab tesirine | 8 | 8 | Antineoplastics |
| nivolumab / relatlimab | 8 | 7 | Antineoplastics |
| tivozanib | 8 | 8 | Antineoplastics |
| chlormethine | 7 | 6 | Antineoplastics |
| cobimetinib | 7 | 7 | Antineoplastics |
| glasdegib | 7 | 6 | Antineoplastics |
| tagraxofusp | 7 | 6 | Antineoplastics |
| talquetamab | 7 | 6 | Antineoplastics |